Tag: Huang Peng
East & Concord advises in tumour-therapy licence win
China’s first commercial-use licensing of boron neutron capture therapy (BNCT) saw East & Concord Partners advising
China’s first commercial-use licensing of boron neutron capture therapy (BNCT) saw East & Concord Partners advising
GCs face increasingly sophisticated cyber-threats while navigating more complex disclosure regulations
Join our mailing list for legal news and alerts
Sign up